Specialty Pharmacy News Roundup: November 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends. 


Catalyst Pharmaceuticals recently reported that Santhera Pharmaceuticals has obtained FDA approval for AGAMREE® (vamorolone) oral suspension 40 mg/mL for use in treating Duchenne Muscular Dystrophy (DMD) in patients aged two years and older. Anovo was selected to work with Catalyst as the exclusive distributor and specialty pharmacy for AGAMREE®. Anovo’s unique business is purpose-built exclusively for niche products designed to treat or impact rare diseases.


Blue Sky Specialty Pharmacy, a provider of comprehensive specialty pharmacy services, announced the BIMZELX Bridge Program along with UCB, Inc. for their latest groundbreaking medication Bimzelx® (bimekizumab-bkzx), which has been approved by the FDA for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Through Blue Sky’s collaboration with the BIMZELX Bridge Program, patients will benefit from  improved access to the medication, enhanced medication monitoring and coordination, streamlined access, and the superior customer service and comprehensive support that Blue Sky is known for.

Expion Health, a pioneer in leveraging powerful technology and dynamic pricing strategies, unveiled its new collaboration with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). This strategic alliance will integrate Cost Plus Drugs’ revolutionary pricing into Expion Health’s product suite, offering an innovative way to tackle the escalating costs of specialty drugs. Expion Health’s Specialty Navigator, now enhanced by Cost Plus Drugs’ distinctive pricing approach, equips payers with a sophisticated tool for navigating this modern landscape.

UCB has selected Kroger Specialty Pharmacy as one of the Network Specialty Pharmacies to dispense BIMZELX® for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Kroger Specialty Pharmacy’s clinical and patient care teams are specially trained in dermatology care. Their unique skills and experience allow them to help navigate the complexities that arise from complex medication therapies.


Perigon Pharmacy 360 (Perigon), a leading precision digital pharmacy, announced its selection to join Paratek Pharmaceuticals’ Limited Distribution Network for their breakthrough drug, NUZYRA®. This strategic partnership seamlessly aligns with Perigon’s mission to provide innovative healthcare solutions to patients in need. NUZYRA (omadacycline) is a novel antibiotic with both once-daily oral and intravenous (IV) formulations, specifically designed for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). The drug’s unique attributes offer healthcare providers new options for treating tetracycline resistant pathogens, as well as flexibility in choosing the most effective mode of administration for individual patients.


Tris Pharma, Inc., a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, announced a new partnership with Perigon Pharmacy 360 to enhance accessibility, affordability and adherence for patients treating symptoms of ADHD with Tris’ DYANAVEL® XR (amphetamine) extended-release tablets. Together, Tris Pharma and Perigon launched a direct-to-patient program, DYANAVEL Delivered, that allows patients and caregivers to seamlessly access DYANAVEL XR extended-release tablets through Perigon’s digital pharmacy, enhance their medication management, and receive reimbursement assistance and support to help navigate their treatment journey while reducing administrative burden for both patients and providers.


Zeal Specialty Pharmacy announced it has achieved accreditation through Accreditation Commission for Health Care (ACHC) for the services of Specialty Pharmacy, along with a distinction in management of Rare Diseases and Orphan Drugs. Zeal is a nationally focused specialty pharmacy, offering the latest technological solutions and clinical services to all patients, particularly those diagnosed with rare and orphan conditions.